Claire McCaskill actually said...
I just wanted to make sure that clearly if you are--what did you say, second? Second largest shareholder in Valeant and you want to talk about drug pricing in Congress, lobbying.
Context
McCaskill emphasizes the lobbying nature of discussing drug pricing as a major shareholder.
04/26/2016